We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$353M
AUM Growth
+$22.9M
Cap. Flow
+$20.2M
Cap. Flow %
5.72%
Top 10 Hldgs %
40.34%
Holding
104
New
6
Increased
21
Reduced
24
Closed
10

Top Buys

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$7.97M
2
JPM icon
JPMorgan Chase
JPM
+$7.83M
3
ABBV icon
AbbVie
ABBV
+$6.04M
4
NVDA icon
NVIDIA
NVDA
+$4.32M
5
XLNX
Xilinx Inc
XLNX
+$4.13M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$8.91M
2
DD icon
DuPont de Nemours
DD
+$6.22M
3
XOM icon
ExxonMobil
XOM
+$1.25M
4
PARA
Paramount Global Class B
PARA
+$780K
5
FTV icon
Fortive
FTV
+$486K

Sector Composition

Rank Sector Weight
1 Healthcare 30.55%
2 Technology 17.29%
3 Communication Services 13.62%
4 Industrials 12.57%
5 Energy 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$31.6M 8.95%
285,549
– –
AAPL icon
2
Apple
AAPL
$4.67T
$18.7M 5.29%
377,792
+3,220
+0.9% +$157K
BX icon
3
Blackstone
BX
$107B
$13.6M 3.86%
306,739
-435
-0.1% -$17.3K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.24T
$12.8M 3.61%
235,680
+1,720
+0.7% +$99.6K
RTN
5
DELISTED
Raytheon Company
RTN
$11.6M 3.28%
66,563
+7,738
+13% +$1.39M
TMO icon
6
Thermo Fisher Scientific
TMO
$230B
$11.4M 3.23%
38,920
– –
UNH icon
7
UnitedHealth
UNH
$353B
$11.4M 3.23%
46,800
+13,163
+39% +$3.17M
EPD icon
8
Enterprise Products Partners
EPD
$84.3B
$10.6M 3.01%
368,549
+17,577
+5% +$506K
CI icon
9
Cigna
CI
$73.7B
$10.6M 3.01%
67,460
+4,450
+7% +$697K
INTC icon
10
Intel
INTC
$473B
$10.1M 2.87%
211,709
+46,831
+28% +$2.32M
META icon
11
Meta Platforms (Facebook)
META
$1.47T
$9.88M 2.8%
51,194
-72
-0.1% -$13.2K
CSCO icon
12
Cisco
CSCO
$433B
$9.26M 2.62%
169,166
-650
-0.4% -$35.9K
NOC icon
13
Northrop Grumman
NOC
$77.5B
$8.64M 2.45%
+26,750
New +$7.97M
CMCSA icon
14
Comcast
CMCSA
$96B
$8.56M 2.42%
202,553
-1,325
-0.6% -$55.9K
AMAT icon
15
Applied Materials
AMAT
$366B
$8.53M 2.41%
189,918
-543
-0.3% -$22.9K
ABBV icon
16
AbbVie
ABBV
$451B
$8.21M 2.32%
112,852
+76,892
+214% +$6.04M
JPM icon
17
JPMorgan Chase
JPM
$951B
$7.94M 2.25%
+71,050
New +$7.83M
MPLX icon
18
MPLX
MPLX
$60.1B
$7.88M 2.23%
244,711
-550
-0.2% -$17.5K
PFE icon
19
Pfizer
PFE
$159B
$7.48M 2.12%
181,933
– –
UNP icon
20
Union Pacific
UNP
$183B
$7.4M 2.09%
43,770
-50
-0.1% -$8.57K
AMGN icon
21
Amgen
AMGN
$234B
$7.1M 2.01%
38,519
+200
+0.5% +$35.8K
MPC icon
22
Marathon Petroleum
MPC
$104B
$7.06M 2%
126,344
-150
-0.1% -$8.21K
BXMT icon
23
Blackstone Mortgage Trust
BXMT
$2.31B
$6.87M 1.95%
193,167
-200
-0.1% -$7.12K
DHR icon
24
Danaher
DHR
$152B
$6.56M 1.86%
51,752
-135
-0.3% -$16K
T icon
25
AT&T
T
$178B
$6.38M 1.8%
251,870
-1,123
-0.4% -$26.9K
1
2 3 4

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Private Capital Advisors held 104 positions worth $353M, up 6.9% from $330M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Private Capital Advisors deployed $20.2M of net new capital in Q2 2019, opening 6 new positions and adding to 21 existing holdings. Its largest new stake was Northrop Grumman: 26,750 shares worth $8.64M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was ExxonMobil, an estimated $1.25M trimmed.

  • Private Capital Advisors's largest Q2 2019 buy was Northrop Grumman: 26,750 shares worth $8.64M.
  • Private Capital Advisors added most to AbbVie in Q2 2019, an estimated $6.04M increase.
  • Private Capital Advisors's biggest Q2 2019 reduction was ExxonMobil, cutting an estimated $1.25M.
  • Private Capital Advisors fully exited iShares Biotechnology ETF in Q2 2019, selling an estimated $8.91M.
  • Private Capital Advisors's ten largest holdings make up 40% of its $353M portfolio in Q2 2019.
  • Private Capital Advisors opened 6 new positions and closed 10 in Q2 2019.
  • Private Capital Advisors's portfolio value rose 6.9% quarter-over-quarter to $353M.

Based on Private Capital Advisors's 13F filing for Q2 2019, filed 18 Jul 2019.